Publicaciones - IR Sant Pau

Buscar

01/10/2024 IMPLEMENTATION OF CYP3 A5 GENOTYPING TO INDIVIDUALISE TACROLIMUS DOSE IN PAEDIATRIC PATIENTS UNDERGOING HAEMATOPOIETIC STEM CELL TRANSPLANTATION

Torija, IL, Mart n, LG, Sanz, PE, Armengol, PR, Chac n, CM, Noguera, SB, Espa ol, MT, Rodriguez, ER, Guerrero, SB, Mart nez, EFD. IMPLEMENTATION OF CYP3 A5 GENOTYPING TO INDIVIDUALISE TACROLIMUS DOSE IN PAEDIATRIC PATIENTS UNDERGOING HAEMATOPOIETIC STEM CELL TRANSPLANTATION. BONE MARROW TRANSPLANTATION. 2024; 59DOI:. PMID:. IF:5.200(Q1/1D).

01/10/2024 Clinical and Dosimetric Predictors of Cardiotoxicity in Thoracic Radiotherapy for Locally Advanced Lung Cancer

Otero, E, Gallego, P, Soto, A, Jornet, N, Rabi, S, Crespo, S, Calvet, G, Sanz, J, Martinez, S, Bermejo, S, Pardo, GS, Farré, N. Clinical and Dosimetric Predictors of Cardiotoxicity in Thoracic Radiotherapy for Locally Advanced Lung Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2024; 120(2)DOI:. PMID:. IF:6.500(Q1/1D).

01/10/2024 Coinfection of monkeypox, COVID-19 and syphilis in a PrEP using MSM: A case report from Barcelona

Vives, A, Muñoz, CA, Alonso-Tarres, C, Cosentino, M. Coinfection of monkeypox, COVID-19 and syphilis in a PrEP using MSM: A case report from Barcelona. Actas Urologicas Espanolas. 2024; 48(8)DOI:10.1016/j.acuro.2024.04.001. PMID:38735435. IF:1.200(Q3/7D).

01/10/2024 Efficacy and safety of hypertonic saline therapy in ambulatory patients with heart failure: The SALT-HF trial

Marcos, MC, de la Espriella, R, Comín-Colet, J, Zegrí-Reiriz, I, Gracia, JR, Morales-Rull, JL, Llàcer, P, Díez-Villanueva, P, Jiménez-Marrero, S, Bagudá, JD, Cortés, CO, Restrepo-Córdoba, MA, Goirigolzarri-Artaza, J, García-Pinilla, JM, Barrios, E, Díaz, SD, Hernández, EM, Sanchez-Marteles, M, Núñez, J. Efficacy and safety of hypertonic saline therapy in ambulatory patients with heart failure: The SALT-HF trial. EUROPEAN JOURNAL OF HEART FAILURE. 2024; 26(10)DOI:10.1002/ejhf.3390. PMID:39056478. IF:10.800(Q1/1D).

01/10/2024 APOLO: Phase II Trial of Induction ChemoImmunotherapy Plus Chemoradiotherapy and Maintenance Immunotherapy in Stage III NSCLC

Provencio, M, Campos, B, Guirado, M, Vilà, L, Campelo, MRG, Dorta, M, Estévez, SV, Ferrandez, A, Sala, MA, Ortega, AL, Blasco, A, Insa, A, Areses, MC, Sullivan, I, Castro, RL, Calvo, V, Rodríguez -Abreu, D, Bosch-Barrera, J, López-Martín, A, Marsé, R, Torrado, L, Matskov, K, Giner, J, Bruno, MF, Saugar, ES, Martínez-Toledo, C, Cruz-Bermudez, A. APOLO: Phase II Trial of Induction ChemoImmunotherapy Plus Chemoradiotherapy and Maintenance Immunotherapy in Stage III NSCLC. Journal of Thoracic Oncology. 2024; 19(10)DOI:. PMID:. IF:20.800(Q1/1D).

01/10/2024 Comparison of assays measuring extracellular vesicle tissue factor in plasma samples: communication from the ISTH SSC Subcommittee on Vascular Biology

Bonifay, A, Mackman, N, Hisada, Y, Sachetto, ATA, Hau, C, Gray, E, Hogwood, J, Aharon, A, Badimon, L, Barile, L, Baudar, J, Beckmann, L, Benedikter, B, Bolis, S, Bouriche, T, Brambilla, M, Burrello, J, Camera, M, Campello, E, Ettelaie, C, Faille, D, Featherby, S, Franco, C, Guldenpfennig, M, Hansen, JB, Judicone, C, Kim, Y, Kristensen, SR, Laakmann, K, Langer, F, Latysheva, N, Lucien, F, Menezes, EMD, Mullier, F, Norris, P, Nybo, J, Orbe, J, Osterud, B, Paramo, JA, Radu, CM, Roncal, C, Samadi, N, Snir, O, Suades, R, Wahlund, C, Chareyre, C, Abdili, E, Martinod, K, Thaler, J, Dignat-George, F, Nieuwland, R, Lacroix, R. Comparison of assays measuring extracellular vesicle tissue factor in plasma samples: communication from the ISTH SSC Subcommittee on Vascular Biology. JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2024; 22(10)DOI:10.1016/j.jtha.2024.05.037. PMID:38925490. IF:5.000(Q1/2D).

01/10/2024 ROLE OF STARD1 IN HEPATIC MITOCHONDRIAL- DERIVED OXYSTEROLS IN THE DEVELOPMENT OF CARDIOVASCULAR DYSFUNCTION IN MASH

Torres, S, Garcia, E, Nuñez, S, Ribas, V, Goicoechea, L, Jaara, H, Roldan, MA, Alvarez, AG, Cenarro, A, Munoz, E, Rico, N, Dantas, AP, Jimenez-Trinidad, FR, Guasch, E, Lopez, X, Rigoll, M, Casas, J, Llorente-Cortes, V, Garcia-Ruiz, C. ROLE OF STARD1 IN HEPATIC MITOCHONDRIAL- DERIVED OXYSTEROLS IN THE DEVELOPMENT OF CARDIOVASCULAR DYSFUNCTION IN MASH. HEPATOLOGY. 2024; 80DOI:. PMID:. IF:15.800(Q1/1D).

01/10/2024 Increased Platelet Adhesiveness in Patients with Venous Thromboembolic Disease

Martinez-Sanchez, J, Torramade-Moix, S, Moreno-Castaño, AB, Llobet, D, Jerez-Dolz, D, Sanchez, P, Carrasco, M, Mojal, S, Moret, C, Camacho, M, Soria, JM, Palomo, M, Martin-Fernandez, L, Vidal, F, Escolar, G, Diaz-Ricart, M, Souto, JC. Increased Platelet Adhesiveness in Patients with Venous Thromboembolic Disease. TH OPEN. 2024; 08(04)DOI:10.1055/s-0044-1800798. PMID:39619107. IF:(Q/D).

01/10/2024 An integrated transcriptomics and genomics approach to detect an X/autosome translocation in a female with Duchenne muscular dystrophy

Segarra-Casas, A, Yépez, V, Demidov, G, Laurie, S, Esteve, A, Gagneur, J, Parkhurst, Y, Muni-Lofra, R, Harris, E, Marini-Bettolo, C, Straub, V, Töpf, A. An integrated transcriptomics and genomics approach to detect an X/autosome translocation in a female with Duchenne muscular dystrophy. NEUROMUSCULAR DISORDERS. 2024; 43DOI:. PMID:. IF:2.800(Q2/5D).

01/10/2024 Genetic mosaicism, an underestimated event in genetically unsolved neuromuscular patients: study of two families

Estévez-Arias, B, Segarra-Casas, A, Ortez, C, Matalonga, L, Carrera-García, L, Expósito-Escudero, J, Jou, C, Codina, A, Jiménez-Mallebrera, C, Martorell, L, Lochmüller, H, Töpf, A, Beltran, S, Hoenicka, J, Palau, F, Martí, I, Gallano, P, Nascimento, A, Natera-de Benito, D, González-Quereda, L. Genetic mosaicism, an underestimated event in genetically unsolved neuromuscular patients: study of two families. NEUROMUSCULAR DISORDERS. 2024; 43DOI:. PMID:. IF:2.800(Q2/5D).

01/10/2024 Familial case of Bethlem myopathy caused by an ALU insertion in COL6A2

Luce, L, Demidov, G, Duff, J, McFarlane, A, Segarra-Casas, A, Laurie, S, de Visser, M, van der Kooi, A, Straub, V, Töpf, A. Familial case of Bethlem myopathy caused by an ALU insertion in COL6A2. NEUROMUSCULAR DISORDERS. 2024; 43DOI:. PMID:. IF:2.800(Q2/5D).

01/10/2024 Monoallelic DAG1 truncating variants in patients with hyperCKemia

Segarra-Casas, A, Trainor, C, Polavarapu, K, Díaz-Manera, J, Gonzalez-Quereda, L, Kirschner, J, de Munain, AL, Nascimento, A, Roos, A, Dowling, J, Muntoni, F, Töpf, A, Straub, V. Monoallelic DAG1 truncating variants in patients with hyperCKemia. NEUROMUSCULAR DISORDERS. 2024; 43DOI:10.1016/j.nmd.2024.07.257. PMID:. IF:2.800(Q2/5D).

01/10/2024 OUTCOME OF PATIENTS WITH SIGNAL-TRANSDUCER AND ACTIVATOR OF OF TRANSCRIPTION 1 MUTATIONS (STAT1) GAIN-OF-FUNCTION VARIANTS AFTER HAEMATOPOIETIC STEM CELL TRANSPLANTATION - AN IEWP/PIDTC STUDY

Buddingh, EP, Slatter, M, Becerra, JCA, Garcia, LA, von Asmuth, E, Baris, S, de la Calle-Mart n, O, Chan, A, Chan, B, Chandrakasan, S, Chellapandian, D, Dara, J, Landsverk, HCE, Farmand, S, Fasth, A, Forbes, L, Formankova, R, Grunebaum, E, Keogh, S, Kiykim, A, K hl, JS, Laberko, A, Lankester, A, Leahy, TR, Lindemans, C, Martinez, C, Mart nez-Mart nez, L, Mitchell, WG, Morris, E, Neven, B, Oved, J, Prazenicova, M, Riviere, JG, Roifman, C, G ltekin, SSK, Sedlacek, P, Shah, A, Vong, L, Leiding, J, Sch tz, C. OUTCOME OF PATIENTS WITH SIGNAL-TRANSDUCER AND ACTIVATOR OF OF TRANSCRIPTION 1 MUTATIONS (STAT1) GAIN-OF-FUNCTION VARIANTS AFTER HAEMATOPOIETIC STEM CELL TRANSPLANTATION - AN IEWP/PIDTC STUDY. BONE MARROW TRANSPLANTATION. 2024; 59DOI:. PMID:. IF:5.200(Q1/1D).

01/10/2024 Cardiometabolic effects of weight loss

Genua, I, Sardà, H, Pérez, A. Cardiometabolic effects of weight loss. Atencion Primaria. 2024; 56(10)DOI:10.1016/j.aprim.2024.102953. PMID:38705132. IF:1.600(Q2/4D).

01/10/2024 Examining the therapeutic landscape of beta-blockers in portal hypertension

Brujats, A, Villanueva, C. Examining the therapeutic landscape of beta-blockers in portal hypertension. Clinical and Molecular Hepatology. 2024; 30(4)DOI:10.3350/cmh.2024.0144. PMID:38447532. IF:16.900(Q1/1D).

01/10/2024 Persistent varices in cured patients: Understanding the role of hepatic venous pressure gradient

Olivas, P, Soler-Perromat, A, Tellez, L, Carrion, JA, Alvarado-Tapias, E, Ferrusquia-Acosta, J, Lens, S, Guerrero, A, Falga, A, Vizcarra, P, Orts, L, Perez-Campuzano, V, Shalaby, S, Torres, S, Baiges, A, Turon, F, Garcia-Pagan, JC, Garcia-Criado, A, Hernandez-Gea, V. Persistent varices in cured patients: Understanding the role of hepatic venous pressure gradient. Jhep Reports. 2024; 6(10)DOI:10.1016/j.jhepr.2024.101170. PMID:39430576. IF:7.500(Q1/2D).

01/10/2024 THE GLOBAL PROFILE OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD): CLINICAL PRESENTATION, HISTOLOGIC STAGE, NON-INVASIVE TESTS AND MORTALITY FROM THE GLOBAL NAFLD/MASLD REGISTRY

Younossi, Z, Alkhouri, N, Hagström, H, Kim, SU, Crespo, J, Castera, L, Zheng, MH, Treeprasertsuk, S, Shalimer, D, Alswat, K, Fan, JG, Roberts, S, Tsochatzis, E, Dunn, W, Wong, V, Yilmaz, Y, Francque, S, de Oliveira, C, Pessoa, MG, Ekstedt, M, Goh, GBB, Duseja, A, Chan, WK, Fernandez, MIC, Sebastiani, G, Lampertico, P, Alnaamani, K, Valsan, AK, Holleboom, AG, El-Kassas, M, Choudhary, NS, Vessby, J, Singal, A, Kakizaki, S, Pearlman, B, Gunn, N, Cordie, A, Mauricio, D, Kawaguchi, T, Nadeem, R, Shang, Y, Lee, HW, Iruzubieta, P, Liu, WY, Ananchuensook, P, Yang, RX, Zoncapé, M, Dunn, N, Song, SJ, Gadi, Z, Teh, KKJ, Mahadeva, S, Fabian, LG, Cinque, F, D'Ambrosio, R, Friend, E, Poca, M, Colombu, M, Allen, A, Lazarus, J, Lam, B, de Avila, L, Racila, A, Alqahtani, S, Stepanova, M. THE GLOBAL PROFILE OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD): CLINICAL PRESENTATION, HISTOLOGIC STAGE, NON-INVASIVE TESTS AND MORTALITY FROM THE GLOBAL NAFLD/MASLD REGISTRY. HEPATOLOGY. 2024; 80DOI:. PMID:. IF:15.800(Q1/1D).

01/10/2024 PTIPS IS ASSOCIATED WITH BETTER OUTCOMES IN PATIENTS WITH ACUTE VARICEAL BLEEDING AND SEVERE ALCOHOLIC HEPATITIS

Hernandez-Gea, RMV, Bouzbib, C, Procopet, B, Aznar, AB, Turon, F, Larrue, H, Sanchez, CV, Albillos, A, Gluud, L, Guardascione, M, Praktiknjo, P, Cots, M, Ridaura, HM, Laleman, W, Bureau, C, Mandorfer, M, Tapias, E, Gallego, AG, Zipprich, A, Hartl, L, Hidalgo, NC, Deckmyn, O, Garcia-Pagan, JC, Thabut, D. PTIPS IS ASSOCIATED WITH BETTER OUTCOMES IN PATIENTS WITH ACUTE VARICEAL BLEEDING AND SEVERE ALCOHOLIC HEPATITIS. HEPATOLOGY. 2024; 80DOI:. PMID:. IF:15.800(Q1/1D).

01/10/2024 Considerations to the comments on the recommendations of the Spanish Antibiogram Committee (COESANT) for the preparation of Cumulative Antibiotic Sensitivity Reports

Navarro, F, Oliver, A, Larrosa, MN. Considerations to the comments on the recommendations of the Spanish Antibiogram Committee (COESANT) for the preparation of Cumulative Antibiotic Sensitivity Reports. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2024; 42(8)DOI:10.1016/j.eimc.2024.03.011. PMID:38763864. IF:2.500(Q2/5D).

01/10/2024 Risk factors for mortality and complications in peripheral venous catheter-associated Staphylococcus aureus bacteraemia: a large multicentre cohort study

Rodríguez, AG, Llorach, PD, Grillo, S, Marabajan, MP, Solchaga, VP, López, AH, Martínez, EJ, Bermudez, IO, Rivera, A, Rojo, MP, González, JLC. Risk factors for mortality and complications in peripheral venous catheter-associated Staphylococcus aureus bacteraemia: a large multicentre cohort study. JOURNAL OF HOSPITAL INFECTION. 2024; 152DOI:10.1016/j.jhin.2024.06.017. PMID:39032565. IF:3.100(Q1/3D).

01/10/2024 Clinical and Serological Profiles in Cryoglobulinemia: Analysis of Isotypes and Etiologies

Codes-Méndez, H, Jeria, S, Park, HS, Moya, P, Magallares-López, B, Moltó, E, Alvaro, Y, Mariscal, A, Moga, E, Tandaipan, JL, Díaz-Torne, C, Laiz, A, Sainz, L, Castellví, I, Corominas, H. Clinical and Serological Profiles in Cryoglobulinemia: Analysis of Isotypes and Etiologies. Journal of Clinical Medicine. 2024; 13(20)DOI:10.3390/jcm13206069. PMID:39458019. IF:2.900(Q1/2D).

01/10/2024 18F-FDG-PET/CT Scan for Detection of Large Vessel Involvement in Giant Cell Arteritis: Arteser Spanish Registry

Estrada, P, Domínguez-Alvaro, M, Melero-González, RB, de Miguel, E, Silva-Díaz, M, Valero, JA, González, I, Sánchez-Martín, J, Narváez, J, Galíndez, E, Mendizábal, J, Iñiguez-Ubiaga, CL, Rodríguez-Rodríguez, L, Loricera, J, Muñoz, A, Moya-Alvarado, P, Moran-alvarez, P, Navarro-angeles, VA, Galisteo, C, Castañeda, S, Blanco, R. 18F-FDG-PET/CT Scan for Detection of Large Vessel Involvement in Giant Cell Arteritis: Arteser Spanish Registry. Journal of Clinical Medicine. 2024; 13(20)DOI:10.3390/jcm13206215. PMID:39458165. IF:2.900(Q1/2D).

01/10/2024 Update of the Consensus Statement of the Spanish Society of Rheumatology on the use of biological and synthetic targeted therapies in rheumatoid arthritis.

Álvaro-Gracia Álvaro JM, Díaz Del Campo Fontecha P, Andréu Sánchez JL, Balsa Criado A, Cáliz Cáliz R, Castrejón Fernández I, Corominas H, Gómez Puerta JA, Manrique Arija S, Mena Vázquez N, Ortiz García A, Plasencia Rodríguez C, Silva Fernández L, Tornero Molina J. Update of the Consensus Statement of the Spanish Society of Rheumatology on the use of biological and synthetic targeted therapies in rheumatoid arthritis.. Reumatologia Clinica. 2024; 20(8)DOI:10.1016/j.reumae.2024.09.002. PMID:39341701. IF:(Q/D).

01/10/2024 Parasympathetic nervous system: A key role in control and mood disorders in patients with asthma

Soto-Retes, L, Milagro, J, Crespo-Lessmann, A, Curto, E, Medina, EFM, Bailon, R, Gil, E, Laguna, P, Plaza, V. Parasympathetic nervous system: A key role in control and mood disorders in patients with asthma. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY. 2024; 133(4)DOI:10.1016/j.anai.2024.07.022. PMID:39074657. IF:4.700(Q1/1D).

01/10/2024 Prediction of COVID-19 severity using machine learning

Karaduzovic-Hadziabdic, K, Adilovic, M, Zhang, L, Lumley, A, Shah, PA, Shoaib, M, Satagopam, V, Srivastava, PK, Emanueli, C, Greco, S, Made, A, Padro, T, Domingo, P, Lustrek, M, Scholz, M, Rosolowski, M, Jordan, M, Benczik, B, Agg, B, Ferdinandy, P, Baker, AH, Fagherazzi, G, Ollert, M, Michel, J, Sanchez, G, Firat, H, Brandenburger, T, Martelli, F, Badimon, L, Devaux, Y. Prediction of COVID-19 severity using machine learning. Clinical and Translational Medicine. 2024; 14(10)DOI:10.1002/ctm2.70042. PMID:39370709. IF:6.800(Q1/2D).

01/10/2024 The proteome of circulating exosomes in appropriate- versus small-for-gestational-age infants: differentially expressed proteins at birth associate with measures of weight gain, liver fat, insulin resistance and adrenarche at age 7

Díaz, M, Quesada, T, Villarroya, F, López-Bermejo, A, Casano, P, De Zegher, F, Ibanez, L. The proteome of circulating exosomes in appropriate- versus small-for-gestational-age infants: differentially expressed proteins at birth associate with measures of weight gain, liver fat, insulin resistance and adrenarche at age 7. Hormone Research in Paediatrics. 2024; 97DOI:. PMID:. IF:2.700(Q1/2D).

01/10/2024 Dual mTOR1/2 Inhibitor Sapanisertib (FTH-003/TAK-228) in Combination With Weekly Paclitaxel in Patients With Previously Treated Metastatic Urothelial Carcinoma: A Phase II Open-Label Study

Bellmunt, J, Maroto, P, Bonfill, T, Vazquez, F, Perez-Gracia, JL, Juanpere, N, Hernandez-Prat, A, Hernandez-Llodra, S, Rovira, A, Juan, OS, Rodriguez-Vida, A. Dual mTOR1/2 Inhibitor Sapanisertib (FTH-003/TAK-228) in Combination With Weekly Paclitaxel in Patients With Previously Treated Metastatic Urothelial Carcinoma: A Phase II Open-Label Study. Clinical Genitourinary Cancer. 2024; 22(5)DOI:10.1016/j.clgc.2024.102123. PMID:38905731. IF:2.700(Q2/3D).

01/10/2024 The impact of previous therapy on overall-survival in registration clinical trials for 1st line metastatic breast cancer a systemic review

Abu Remilah, A, Krayim, B, Amir, E, Tibau, A, Robson, ME, Abuhadra, N, Chen, Y, Shepshelovich, D, Goldvaser, H. The impact of previous therapy on overall-survival in registration clinical trials for 1st line metastatic breast cancer a systemic review. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2024; 202DOI:10.1016/j.critrevonc.2024.104455. PMID:39067779. IF:5.600(Q1/2D).

01/10/2024 Prognostic Laboratory Parameters in Imfirst: Atezolizumab Plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer

de Castro, J, Dols, MC, Gómez, MD, Vega, AM, Aix, SP, Arriola, E, Carcereny, E, Majem, M, Vence, GH, González, EE, Pradera, JF, Granados, ALO, Morales, MG, Sureda, BM, Núñez, NF, Provencio, M, González-Mancha, N, Fajardo, CA, Lerones, N, Campelo, RG. Prognostic Laboratory Parameters in Imfirst: Atezolizumab Plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer. Journal of Thoracic Oncology. 2024; 19(10)DOI:. PMID:. IF:20.800(Q1/1D).

01/10/2024 Association of Pathologic Regression with EFS in the KEYNOTE-671 Study of Perioperative Pembrolizumab for Early-Stage NSCLC

Jones, DR, Wakelee, H, Spicer, JD, Liberman, M, Kato, T, Tsuboi, M, Lee, SH, Wang, W, Chen, H, Dooms, C, Majem, M, Eigendorff, E, Martinengo, GL, Bylicki, O, Huang, HC, Novello, S, Jensen, E, Keller, SM, Samkari, A, Kalhor, N. Association of Pathologic Regression with EFS in the KEYNOTE-671 Study of Perioperative Pembrolizumab for Early-Stage NSCLC. Journal of Thoracic Oncology. 2024; 19(10)DOI:. PMID:. IF:20.800(Q1/1D).

01/10/2024 An Evidence-Driven Approach to Optimizing Clinical, Operational, And Economic Value in the Lung Cancer Care Pathway

Majem, M, Sullivan, IG, Torrego, A, Surrallés, J, Purdy, J, Carmona, MA, Dunsford, H, Wubs, M. An Evidence-Driven Approach to Optimizing Clinical, Operational, And Economic Value in the Lung Cancer Care Pathway. Journal of Thoracic Oncology. 2024; 19(10)DOI:. PMID:. IF:20.800(Q1/1D).

01/10/2024 Basal Circulating Leukocyte-Platelet Complexes and PD-L1 Expression on Circulating Cells in Patients with Advanced SCLC

Piedra, A, Guinart-Cuadra, A, Mulet, M, Zamora, C, Alejandre, J, Martínez-Recio, S, Barba, A, Sullivan, I, Serra-López, J, Isla, D, Arriola, E, Paz-Ares, L, Diz, MP, Moreno, AL, Callejo, A, Vidal, S, Majem, M. Basal Circulating Leukocyte-Platelet Complexes and PD-L1 Expression on Circulating Cells in Patients with Advanced SCLC. Journal of Thoracic Oncology. 2024; 19(10)DOI:. PMID:. IF:20.800(Q1/1D).

01/10/2024 Five-Year Clinical Outcomes of Perioperative Nivolumab and Chemotherapy in Stage III Non-SmallCell Lung Cancer (NADIM Trial)

Provencio, M, Nadal, E, Insa, A, Campelo, MRG, Calvo, V, Palmero, R, Lázaro, M, Dómine, M, Majem, M, Rodríguez-Abreu, D, Martínez-Martí, A, Carpeño, JDC, Cobo, M, Bernabé, R, Viñolas, N, Barneto, I, Viteri, S, Cruz-Bermudez, A, Romero, A, Massutí, B. Five-Year Clinical Outcomes of Perioperative Nivolumab and Chemotherapy in Stage III Non-SmallCell Lung Cancer (NADIM Trial). Journal of Thoracic Oncology. 2024; 19(10)DOI:. PMID:. IF:20.800(Q1/1D).

01/10/2024 Patterns of Disease Progression after Atezolizumab Plus Chemotherapy in ES-SCLC: Exploratory Analysis from IMfirst Study

Garcia-Campelo, R, Gómez, MD, de Castro, J, Vega, AM, Aix, SP, Arriola, E, Carcereny, E, Majem, M, Vence, GH, González, EE, Pradera, JF, Granados, ALO, Morales, MG, Sureda, BM, Núñez, NF, Provencio, M, González-Mancha, N, Fajardo, CA, Lerones, N, Dols, MC. Patterns of Disease Progression after Atezolizumab Plus Chemotherapy in ES-SCLC: Exploratory Analysis from IMfirst Study. Journal of Thoracic Oncology. 2024; 19(10)DOI:. PMID:. IF:20.800(Q1/1D).

01/10/2024 TCR Metrics as Predictive Biomarkers of Response and Survival after Perioperative Chemoimmunotherapy. NADIM & NADIM II Trials

Martínez-Toledo, C, Sierra, B, Molina-Alejandre, M, Casarrubios, M, Calvo, V, Nadal, E, Campelo, MRG, Martínez-Martí, A, Garrido, A, Massutí, B, Insa, A, De Castro, J, Dóomine, M, González-Larriba, JL, Majem, M, Ponce, S, Barneto, I, Aguilar, A, Martín-López, J, Provencio, M, Cruz-Bermúdez, A. TCR Metrics as Predictive Biomarkers of Response and Survival after Perioperative Chemoimmunotherapy. NADIM & NADIM II Trials. Journal of Thoracic Oncology. 2024; 19(10)DOI:. PMID:. IF:20.800(Q1/1D).

01/10/2024 Volrustomig plus platinum doublet chemotherapy (CTx) in first-line non-small cell lung cancer (NSCLC): Phase 1b trial update

Spigel, DR, Ahn, MJ, Majem, M, Rodríguez, LM, Lee, KH, Carcereny, E, Hernández, AA, Insa, A, Cho, EK, Besse, B, Rha, SY, Weiss, J, D'Arcangelo, M, Im, SA, Kim, SW, Carneiro, BA, Gadgeel, SM, Mitchell, P, Asare, JM, Gainer, SD, Achour, I, Subramaniam, DS, Felip, E. Volrustomig plus platinum doublet chemotherapy (CTx) in first-line non-small cell lung cancer (NSCLC): Phase 1b trial update. Journal of Thoracic Oncology. 2024; 19(10)DOI:. PMID:. IF:20.800(Q1/1D).

01/10/2024 Amivantamab Plus Lazertinib vs Osimertinib in First Line, EGFR-Mutant Advanced NSCLC: Patientrelevant Outcomes from MARIPOSA

Nguyen, D, Besse, B, Cho, BC, Lee, SH, Lee, KH, Lu, S, Cheng, Y, Yao, Y, Girard, N, Lin, CC, Felip, E, Aguilar, A, Charoentum, C, Cruz, FJSM, Majem, M, Lim, CS, Akamatsu, H, Hayashi, H, Yang, JCH, Kowalyszyn, R, Tiscoski, K, Franke, F, Ponomarenko, D, Arslan, C, Forster, M, Urban, D, Misch, D, Delmonte, A, Montes, LVG, Gadgeel, SM, Cruz-Correa, M, Peguero, J, Rousey, S, Gaffar, Y, Owen, S, Schuchard, J, Diels, J, Sermon, J, Sun, T, Ennis, M, Fennema, E, Daksh, M, Sethi, S, Bauml, JM, Campelo, MRG. Amivantamab Plus Lazertinib vs Osimertinib in First Line, EGFR-Mutant Advanced NSCLC: Patientrelevant Outcomes from MARIPOSA. Journal of Thoracic Oncology. 2024; 19(10)DOI:. PMID:. IF:20.800(Q1/1D).

01/10/2024 From the Rare to the Extraordinary Pancreatic Serous Cystadenocarcinoma With Hepatic and Bone Dissemination: A Letter to the Editor

Cardozo, A, Lleida, R, Szafranska, J, Piñol, D, Serdà, P, Martin-Cullell, B, Manrique, A, López-Bravo, D, Mateo, FJ. From the Rare to the Extraordinary Pancreatic Serous Cystadenocarcinoma With Hepatic and Bone Dissemination: A Letter to the Editor. PANCREAS. 2024; 53(9)DOI:10.1097/MPA.0000000000002362. PMID:39250559. IF:1.700(Q3/8D).

01/10/2024 RET overexpression in absence of fusions or mutations associates with sensitivity to RET TKIs in lung cancer

Sullivan, I, Aguado, C, Baroni, M, Teixeira, S, Bertran, J, Giménez, A, Aldeguer, E, Román, R, Reguart, N, López, L, Cavagna, R, Marín, E, García, B, Rodriguez, S, Rosell, R, Ferro, L, Chae, Y, Reis, R, Molina, MA. RET overexpression in absence of fusions or mutations associates with sensitivity to RET TKIs in lung cancer. EUROPEAN JOURNAL OF CANCER. 2024; 211DOI:10.1016/j.ejca.2024.114800. PMID:. IF:7.100(Q1/2D).

01/10/2024 Comparison of Three Graft-versus-Host Disease Prophylaxis Strategies after T Cell-Replete Haploidentical Hematopoietic Transplantation: Tacrolimus versus Calcineurin Inhibitors plus Mycophenolate Mofetil versus Sirolimus plus Mycophenolate Mofetil

Esquirol, A, Pascual, MJ, Montoro, J, Piñana, JL, Ferrà, C, Herruzo, B, Garcia-Cadenas, I, Balaguer, A, Perez, A, Huguet, M, Redondo, S, Villalba, M, Hernandez-Boluda, JC, Chorao, P, Hernani, R, Sanz, J, Solano, C, Sierra, J, Martino, R. Comparison of Three Graft-versus-Host Disease Prophylaxis Strategies after T Cell-Replete Haploidentical Hematopoietic Transplantation: Tacrolimus versus Calcineurin Inhibitors plus Mycophenolate Mofetil versus Sirolimus plus Mycophenolate Mofetil. Transplantation And Cellular Therapy. 2024; 30(10)DOI:10.1016/j.jtct.2024.07.027. PMID:39116938. IF:4.400(Q1/1D).